Form 8-K - Current report:
SEC Accession No. 0001437749-25-025814
Filing Date
2025-08-11
Accepted
2025-08-11 08:14:32
Documents
15
Period of Report
2025-08-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K crvo20250808_8k.htm   iXBRL 8-K 29895
2 EXHIBIT 99.1 ex_850337.htm EX-99.1 121311
7 logosmlr.jpg GRAPHIC 3845
  Complete submission text file 0001437749-25-025814.txt   300217

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA crvo-20250811.xsd EX-101.SCH 3578
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crvo-20250811_def.xml EX-101.DEF 11423
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE crvo-20250811_lab.xml EX-101.LAB 15309
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crvo-20250811_pre.xml EX-101.PRE 11583
17 EXTRACTED XBRL INSTANCE DOCUMENT crvo20250808_8k_htm.xml XML 2829
Mailing Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116
Business Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116 (617) 744-4400
CervoMed Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)